Korea needs to lessen defective rate of finished pharmaceuticals via automated process

"Korea's pharmaceutical makers should step up their efforts to curb the occurrence of defective drugs," said a Japanese director.

K. Nakamura, a technical director of Japan's Packaging Machinery Association, contended that although Korea's drug production technology itself is not inferior to other advanced countries, the final process of checking defective items requires more improvement due...